News

Genetic causes of miscarriages without secrets – a revolutionary diagnostic method

More than 60% of miscarriages are caused by chromosomal defects of the embryo or fetus. Sensitive diagnostic tools are needed to provide accurate diagnosis of the […]

Read more

Test Fragment Accuracy – simple way to measure Your PGS/PGD procedure quality

Next generation sequencing (NGS) technologies produce millions of sequences in a single sequencing run. Prior to analyzing this huge amount of data, it is crucial to […]

Read more

Peek into the future – Genetic Testing

The information contained in the genes determines appearance, influences personality traits, likes and dislikes, and abilities. They affect the extent of predispositions to certain diseases or […]

Read more

Invicta at European Human Genetics Conference

The European Human Genetics Conference  has become one of the premier events in the field of human genetics, where the latest developments are discussed. EHGC was […]

Read more

Polish Leader in Genetic Diagnosis for Reproductive Medicine at ESHRE

The 31st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) was held this year in Lisbon, Portugal from the 14th to the […]

Read more

INVICTA PGS NGS 360˚™ – exclusive and reliable but very simple in use

Next Generation Sequencing is the latest and highly sophisticated technique of molecular diagnosis. At the same time PGS NGS 360˚™ procedure does not require any special […]

Read more

ESHRE 2015 – Invitation, part 3 !

We hope to see you at INVICTA stand during ESHRE 2015 in Lisbon! The ESHRE Congress is being held from June 14 until June 17 at […]

Read more

NGS in ART – simplicity, versatility and trustworthiness

Next Generation Sequencing (NGS) as the newest form of sequencing technique has caused a paradigm shift in many fields of basic and applied science, and is […]

Read more

ESHRE 2015 – Invitation, part 2 !

INVICTA Genetic Laboratory is pleased to invite you to visit our stand during the 31st Congress of the European Society of Human Reproduction and Embryology (ESHRE) […]

Read more

Helping to avoid miscarriages – FertiGenes Test™ – Miscarriages

Women who had experienced at least two miscarriages can perform a test to detect mutations in genes predisposing them to the development of thromboembolism (thrombosis). Blood […]

Read more

ESHRE 2015 – Invitation !

  INVICTA Genetic Laboratory is pleased to invite you to visit our stand during the 31st Congress of the European Society of Human Reproduction and Embryology […]

Read more

How to choose a test ?

Appropriate plan for diagnostic testing can be prepared with help from a clinical geneticist. After an interview and examination of patient’s situation, she will be able […]

Read more

Implantation rate with PGS-NGS 360°™ up to 61,5% – as published in Fertility & Sterility

It is well established that human oocytes are extremely often aneuploid. It is the most common chromosome abnormality in humans and the leading genetic cause of […]

Read more

Success rates with PGS-NGS 360°™ up to 84,4% – as published in Fertility & Sterility

Even in young women more than 50% of cleavage-stage embryos are chromosomally abnormal and it increases up to almost 100% with woman’s age. Aneuploidies are very […]

Read more